Acrivon Therapeutics, Inc. · NASDAQ:ACRV

Blume-Jensen Peter had 1,743 Acrivon Therapeutics, Inc. shares withheld for tax (Form 4)

Traded May 14, 2026 · Filed May 18, 2026

On May 14, 2026, Blume-Jensen Peter (Director, President and CEO) had 1,743 Acrivon Therapeutics, Inc. shares withheld for tax at US$1.92 for US$3,347, leaving 313,637 shares. Filed May 18, 2026 (Form 4).

Withheld for tax
1,743 shares
Price
US$1.92
Value
US$3,347
Holding after
313,637 shares (held indirectly)
Trading plan
No
Role
Director, President and CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 14, 2026Common StockShares withheld for tax1,253US$1.922,078,951Direct
May 14, 2026Common StockShares withheld for tax490US$1.92313,637Indirect

Source

View original at SEC

Related